Visualize more biomarkers and extract more insights: Moving from single marker IHC to multiplex IF

Scott is an associate scientist in the Molecular and Digital Pathology Laboratory for Leidos Biomedical Inc. The group primarily supports the Division of Cancer Epidemiology and Genetics (DCEG) of the NCI with all histopathology applications from tissue preparation though staining, imaging, and analysis. He started his career in a veterinary histopathology lab where he established digital imaging and analysis applications for preclinical work in mice and rats. Afterwards he worked with a pharmacodynamics group developing slide-based assays for phase 0 clinical trials focusing on standardizing multiplex immunofluorescent acquisition and analysis of tissue and circulating tumor cells. Scott has worked in the field for over 17 years bridging experience from the histology wet lab with digital imaging, automation, and analysis.

Dr. Patel is the Associate Director of Biomarker Strategy & Applications at Ultivue. Prior to joining Ultivue, Dr. Patel was a Product Manager at PerkinElmer for the Quantitative Pathology Solutions group where he managed their multiplex IHC portfolio. He is a trained immunologist and has focused his professional career on developing reagent-driven solutions for high-definition multiplex biological imaging in situ and creating innovative biomarker strategies within the fields of immuno-oncology and immuno-therapy research. Over the course of his career, Dr. Patel has worked with a variety of multiplex reagents, instruments, and bioinformatics tools. He earned his PhD from the University of Massachusetts, Amherst in Microbiology, focusing on Infectious Diseases & Immunology.